Skip to content
A transmembrane protein embedded in a cell membrane, highlighted as a disease-relevant target

Target Identification

TargetIdentification

Discover precise biological targets with AI-driven multi-omics and systems biology, revealing new opportunities for transformative therapies.

  • Multi-omics integrationUnify genomics, transcriptomics, proteomics and clinical data for a complete disease view.
  • Disease pathway analysisMap complex biology to identify high-confidence, causally linked targets.
  • Novel target discoveryUse network biology to uncover previously inaccessible biology.
  • Therapeutic validationPrioritise and validate targets with predictive models and translational evidence.
Explore the platformView pipeline

Method

Discover · Prioritise · Validate · Transform

  1. 01

    Discover

    Differential expression, genetic association and network propagation surface every plausible target for a disease.

    Breadth

  2. 02

    Prioritise

    An explainable score weighs causal genetics, tissue specificity, tractability, safety liabilities and novelty.

    Explainability

  3. 03

    Validate

    Top targets are tested with knock-down, knock-out or pharmacological perturbation in disease-relevant cells.

    Bench evidence

  4. 04

    Transform

    Validated targets move directly into molecular design with their full evidence dossier attached.

    Hand-off

Evidence sources

What the evidence engine reads

  • Human genetics

    GWAS, rare-variant burden and Mendelian randomisation to separate cause from correlation.

  • Single-cell and bulk RNA-seq

    Cell-type-resolved expression in diseased versus healthy tissue.

  • Proteomics

    Protein abundance and post-translational signals that transcripts miss.

  • Pathways and interactions

    Network context that shows where a target sits in disease biology.

  • Literature and patents

    Structured knowledge-graph extraction to track what is known and what is crowded.

  • Safety signals

    Essentiality, tissue expression and known phenotypes flag liabilities early.

Output

A target dossier, not just a score

Each nominated target is delivered with a structured dossier: supporting and contradicting evidence, tractability assessment for each modality, competitive landscape and the validation experiments already run.

The dossier travels with the target into design, so chemists and biologists work from the same evidence.

Evidence engine — illustrative

Targets evaluated
1,240Placeholder
Advanced to validation
18Placeholder
Median dossier size
40+ evidence itemsPlaceholder

Illustrative figures; to be replaced with audited platform metrics.

Bring us a disease. We will bring the evidence.

Collaborate on a focused target-discovery project in your therapeutic area.

Start a conversation